Status:
COMPLETED
Effect of Glucomannan Supplementation on Body Weight in Overweight and Obese Children
Lead Sponsor:
Medical University of Warsaw
Conditions:
Obesity
Overweight
Eligibility:
All Genders
6-17 years
Phase:
PHASE4
Brief Summary
Glucomannan (GNN), a water-soluble dietary fiber derived from the plant Amorphophallus konjac, is marketed for weight reduction. The exact mechanisms by which GNN might exert its actions are unclear. ...
Detailed Description
Methods and analysis Children aged 6 to 17 years with overweight and obesity (based on the WHO growth criteria) will be randomly assigned to receive GNN or placebo (maltodextrin) (both at a dose of 3...
Eligibility Criteria
Inclusion
- age 6-17 years;
- overweight or obesity based on the WHO (World Health Organization) growth charts/references (\>+1 standard deviation \[SD\] or \>+2 SD, respectively)
Exclusion
- drug therapy for a chronic disease (including drugs that influence appetite or body weight);
- type 1 or 2 diabetes;
- history of surgical treatment of obesity;
- participation in another program for treating obesity during the project and/or 3 months prior to recruitment;
- secondary causes of obesity;
- pregnancy.
Key Trial Info
Start Date :
April 27 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 28 2018
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT02280772
Start Date
April 27 2015
End Date
March 28 2018
Last Update
July 20 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Medical University of Warsaw, Department of Paediatrics
Warsaw, Masovian Voivodeship, Poland, 02-091